631
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Antagonizing the innate pattern recognition receptor CD204 to improve dendritic cell-targeted cancer immunotherapy

&
Pages 770-772 | Published online: 24 Aug 2012

References

  • Wang XY, Facciponte JG, Subjeck JR. Molecular chaperones and cancer immunotherapy. Handb Exp Pharmacol 2006; 172:305 - 29; http://dx.doi.org/10.1007/3-540-29717-0_13; PMID: 16610365
  • Wang XY, Facciponte J, Chen X, Subjeck JR, Repasky EA. Scavenger receptor-A negatively regulates antitumor immunity. Cancer Res 2007; 67:4996 - 5002; http://dx.doi.org/10.1158/0008-5472.CAN-06-3138; PMID: 17510431
  • Yi H, Yu X, Gao P, Wang Y, Baek SH, Chen X, et al. Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 2009; 113:5819 - 28; http://dx.doi.org/10.1182/blood-2008-11-190033; PMID: 19349620
  • Yu X, Yi H, Guo C, Zuo D, Wang Y, Kim HL, et al. Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. J Biol Chem 2011; 286:18795 - 806; http://dx.doi.org/10.1074/jbc.M111.224345; PMID: 21460221
  • Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050 - 9; http://dx.doi.org/10.1038/nm1622; PMID: 17704786
  • Qian J, Yi H, Guo C, Yu X, Zuo D, Chen X, et al. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. J Immunol 2011; 187:2905 - 14; http://dx.doi.org/10.4049/jimmunol.1100703; PMID: 21832164
  • Guo C, Yi H, Yu X, Hu F, Zuo D, Subjeck JR, et al. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response. Immunol Cell Biol 2012; 90:101 - 8; http://dx.doi.org/10.1038/icb.2011.10; PMID: 21383767
  • Yi H, Zuo D, Yu X, Hu F, Manjili MH, Chen Z, et al. Suppression of antigen-specific CD4(+) T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell. J Mol Med (Berl) 2011; http://dx.doi.org/10.1007/s00109-011-0828-1; PMID: 22083206
  • Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, et al. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Res 2011; 71:6611 - 20; http://dx.doi.org/10.1158/0008-5472.CAN-11-1801; PMID: 21914786
  • Bak SP, Walters JJ, Takeya M, Conejo-Garcia JR, Berwin BL. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. Cancer Res 2007; 67:4783 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-4410; PMID: 17510407